RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization

Cancer Research

Volumn 65, Issue 17, 2005, Pages 7743-7750

  Ito, Kosei ^a,b   Liu, Qiang ^b   Salto Tellez, Manuel ^b,c   Yano, Takashi ^a   Tada, Kotaro ^b   Ida, Hiroshi ^a   Huang, Canhua ^b   Shah, Nilesh ^b   Inoue, Masafumi ^a,b   Rajnakova, Andrea ^c   Hiong, Kum Chew ^b   Peh, Bee Keow ^b   Han, Hwan Chour ^b   Ito, Tomoko ^b   Teh, Ming ^c   Yeoh, Khay Guan ^c   Ito, Yoshiaki ^a,b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b Oncology Research Institute   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METHYLATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; CORE BINDING FACTOR ALPHA 3 SUBUNIT; COS CELLS; CYTOPLASM; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; STOMACH; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 24744470103     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0743     Document Type: Article

References (42)

1. Yagi Y, Seshimo A, Kameoka S. Prognostic factors in stage IV gastric cancer: univariate and multivariate analyses. Gastric Cancer 2000;3:71-80.
2. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-5.
3. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell 2004;5:121-5.
4. Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-24.
5. Hanai JI, Chen LF, Kanno T, et al. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Cα promoter. J Biol Chem 1999;274:31577-82.
6. Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29.
7. Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 is a major activator of TGFβ1 in vivo. Cell 1998;93:1159-70.
8. Fukamachi H, Ito K, Ito Y. Runx3-/- gastric epithelial cells differentiate into intestinal type cells. Biochem Biophys Res Commun 2004;321:58-64.
9. Fukamachi H, Ito K. Growth regulation of gastric epithelial cells by Runx3. Oncogene 2004;23:4330-5.
10. Ito Y, Miyazono K. RUNX transcription factors as key targets of TGF-β superfamily signaling. Curr Opin Genet Dev 2003;13:43-7.
11. Galfre G, Howe SC, Milstein C, Butcher GW, Howard JC. Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 1997;266:550-2.
12. Zhang YW, Bae SC, Huang G, et al. A novel transcript encoding an N-terminally truncated AML1/PEBP2αB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Mol Cell Biol 1997;17:4133-45.
13. Zhang YW, Yasui N, Ito K, et al. A RUNX2/PEBP2αA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A 2000;97:10549-54.
14. Bae SC, Takahashi E, Zhang YW, et al. Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain. Gene 1995;159:245-8.
15. Bae SC, Ogawa E, Maruyama M, et al. PEB2αB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol Cell Biol 1994;14:3242-52.
16. Ogawa E, Maruyama M, Kagoshima H, et al. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci U S A 1993;90:6859-63.
17. Guo W, Weng L, Ito K, et al. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene 2002;21:8351-5.
18. Mizushima S, Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 1990;18:5322.
19. Salto-Tellez M, Lee SC, Chiu LL, Lee CK, Yong MC, Koay ESC. Microsatellite instability in colorectal cancer - considerations for molecular diagnosis and high-throughput screening of archival tissues. Clin Chem 2004;50:1082-6.
20. Ji J, Chen X, Leung SY, et al. Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Oncogene 2002;21:6549-56.
21. Lu J, Maruyama M, Satake M, et al. Subcellular localization of the α and β subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Mol Cell Biol 1995;15:1651-61.
22. Han SU, Kim HT, Seong DH, et al. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 2004;23:1333-41.
23. Ito Y. Molecular basis of tissue-specific gene expression mediated by the Runt domain transcription factor PEBP2/CBF. Genes Cells 1999;4:685-96.
24. WAP1/Cip1 expression in cooperation with TGF-β-activated SMAD. Mol Cell Biol. In press 2005.
25. Xu L, Massagué J. Nucleocytoplasmic shuttling of signal transducers. Nat Rev Mol Cell Biol 2004;5:209-19.
26. Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int 2000;50:767-77.
27. Kim S, Koga T, Isobe M, et al. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 2003;17:1979-91.
28. Tebbutt NC, Giraud AS, Inglese M, et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 2002;8:1089-97.
29. Huang G, Shigesada K, Ito K, Wee HJ, Yokomizo T, Ito Y. Dimerization with PEBP2β protects RUNX1/AML1 from ubiqutin-proteasome-mediated degradation. EMBO J 2001;20:723-33.
30. Yanagawa N, Tamura G, Oizumi H, Takahashi N, Motoyama T. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 2003;94:589-92.
31. Li QL, Kim HR, Kim WJ, et al. Transcriptional silencing of RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 2004;314:223-8.
32. Kim TY, Lee HJ, Hwang KS, et al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 2004;84:479-84.
33. Wada M, Yazumi S, Takaishi S, et al. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Oncogene 2004;23:2401-7.
34. Xiao WH, Liu WW. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 2004;10:376-80.
35. Ku JL, Kang SB, Shin YK, et al. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 2004;23:6736-42.
36. Goel A, Arnold CN, Tassone P, et al. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int J Cancer 2004;112:754-9.
37. Takahashi T, Shivapurkar N, Riquelme E, et al. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res 2004;10:6126-33.
38. Kang GH, Lee S, Lee HJ, Hwang KS. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol 2004;202:233-40.
39. Torquati A, O'Rear L, Longobardi L, Spagnoli A, Richards WO, Daniel Beauchamp R. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor β responsiveness in esophageal adenocarcinoma cells. Surgery 2004;136:310-6.
40. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 2003;94:360-4.
41. Oshimo Y, Oue N, Mitani Y, et al. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Pathobiology 2004;71:137-43.
42. Kato N, Tamura G, Fukase M, Shibuya H, Motoyama T. Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants. Am J Pathol 2003;163:387-91.